Trial Profile
Phase IIb trial investigating the efficacy and tolerability of AST 120 [charcoal] in patients with non-constipating irritable bowel syndrome
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 May 2010
Price :
$35
*
At a glance
- Drugs Charcoal (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 06 May 2010 New trial record